Then, by introducing studies on the direct delivery of BH3‐mimetics, this review finally proposes an innovative approach for the “conserved conveyance” of drugs to effectively cotarget cancer cells and activated platelets at the site of CAT. The gene discussed is CAT; the disease is cancer.